Cargando…

Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction

BACKGROUND: Mediastinal lymphadenopathy in combination with lung cancer is suggestive for lymph node metastases but can also have other origins. CASE REPORT: We describe a patient diagnosed with stage IV lung cancer presenting with parenchymal lesions and enlarged mediastinal lymph nodes. A second o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schook, Romane M., Koudstaal, Lyan, Comans, Emile F., Postmus, Pieter E., Grünberg, Katrien, Paul, Marinus A., Smit, Egbert F., Sutedja, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246249/
https://www.ncbi.nlm.nih.gov/pubmed/26029554
http://dx.doi.org/10.1016/j.rmcr.2014.07.002
_version_ 1782346499733061632
author Schook, Romane M.
Koudstaal, Lyan
Comans, Emile F.
Postmus, Pieter E.
Grünberg, Katrien
Paul, Marinus A.
Smit, Egbert F.
Sutedja, Thomas G.
author_facet Schook, Romane M.
Koudstaal, Lyan
Comans, Emile F.
Postmus, Pieter E.
Grünberg, Katrien
Paul, Marinus A.
Smit, Egbert F.
Sutedja, Thomas G.
author_sort Schook, Romane M.
collection PubMed
description BACKGROUND: Mediastinal lymphadenopathy in combination with lung cancer is suggestive for lymph node metastases but can also have other origins. CASE REPORT: We describe a patient diagnosed with stage IV lung cancer presenting with parenchymal lesions and enlarged mediastinal lymph nodes. A second opinion including FDG-PET scan review and a mediastinoscopy followed by surgery revealed tumor specimens originating from a single primary tumor with a sarcoid-like reaction in the mediastinal lymph nodes, changing the diagnosis from metastasized to resectable lung cancer. DISCUSSION: PET positive lesions are not always synonymous with metastatic disease in the presence of a malignant tumor. Conscientious review of FDG-PET scans and tissue sampling are therefore mandatory to determine definitive staging and subsequent interventions.
format Online
Article
Text
id pubmed-4246249
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42462492014-12-03 Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction Schook, Romane M. Koudstaal, Lyan Comans, Emile F. Postmus, Pieter E. Grünberg, Katrien Paul, Marinus A. Smit, Egbert F. Sutedja, Thomas G. Respir Med Case Rep Case Report BACKGROUND: Mediastinal lymphadenopathy in combination with lung cancer is suggestive for lymph node metastases but can also have other origins. CASE REPORT: We describe a patient diagnosed with stage IV lung cancer presenting with parenchymal lesions and enlarged mediastinal lymph nodes. A second opinion including FDG-PET scan review and a mediastinoscopy followed by surgery revealed tumor specimens originating from a single primary tumor with a sarcoid-like reaction in the mediastinal lymph nodes, changing the diagnosis from metastasized to resectable lung cancer. DISCUSSION: PET positive lesions are not always synonymous with metastatic disease in the presence of a malignant tumor. Conscientious review of FDG-PET scans and tissue sampling are therefore mandatory to determine definitive staging and subsequent interventions. Elsevier 2014-08-12 /pmc/articles/PMC4246249/ /pubmed/26029554 http://dx.doi.org/10.1016/j.rmcr.2014.07.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Case Report
Schook, Romane M.
Koudstaal, Lyan
Comans, Emile F.
Postmus, Pieter E.
Grünberg, Katrien
Paul, Marinus A.
Smit, Egbert F.
Sutedja, Thomas G.
Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title_full Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title_fullStr Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title_full_unstemmed Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title_short Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
title_sort benefit of a second opinion: from metastatic disease to resectable lung cancer with sarcoid-like reaction
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246249/
https://www.ncbi.nlm.nih.gov/pubmed/26029554
http://dx.doi.org/10.1016/j.rmcr.2014.07.002
work_keys_str_mv AT schookromanem benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT koudstaallyan benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT comansemilef benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT postmuspietere benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT grunbergkatrien benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT paulmarinusa benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT smitegbertf benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction
AT sutedjathomasg benefitofasecondopinionfrommetastaticdiseasetoresectablelungcancerwithsarcoidlikereaction